微信公众号

官网二维码
中国癌症防治杂志

中国癌症防治杂志 ›› 2021, Vol. 13 ›› Issue (2): 164-169.doi: 10.3969/j.issn.1674-5671.2021.02.09

• 癌情监测 • 上一篇    下一篇

2017年福建省肿瘤登记地区肝癌发病和死亡分析

  

  1. 福建省肿瘤医院，福建医科大学附属肿瘤医院 
  • 出版日期:2021-04-25 发布日期:2021-04-30
  • 通讯作者: 周衍 E-mail：316167389@qq.com

An analysis of incidence and mortality of liver cancer in Fujian cancer registries,2017

  • Online:2021-04-25 Published:2021-04-30
  • Supported by:
    福建省卫生计生中青年骨干人才培养项目（2018-ZQN-17）

PDF (PC)

491

赞

摘要：  目的 分析2017年福建省肿瘤登记地区肝癌发病和死亡数据，为肝癌防治策略制定和评估提供科学依据。方法 根据全国肿瘤登记中心制定的数据审核和评价方法，对福建省12个肿瘤登记处上报的2017年数据进行评价，将符合要求的10个登记处数据合并分析。按城乡、性别和年龄组分别计算肝癌发病和死亡粗率、标化率、累积率（0~74岁）。中国人口标化率（简称中标率）根据2000年中国标准人口构成计算，世界人口标化率（简称世标率）按照Segi's标准人口构成计算。结果2017年福建省10个肿瘤登记处共覆盖登记人口6 588 959人，城市地区占43.89%，农村地区占56.11%。2017年福建省肿瘤登记地区肝癌发病率为31.14/10万（男性48.02/10万，女性13.70/10万），中标率为22.51/10万，世标率为21.70/10万。农村地区发病率（中标率23.87/10万，世标率22.90/10万）高于城市地区（中标率20.81/10万，世标率20.16/10万）。2017年福建省肿瘤登记地区肝癌死亡率为28.09/10万（男性43.78/10万，女性11.88/10万），中标率为20.04/10万，世标率为19.45/10万。农村地区死亡率（中标率20.91/10万，世标率20.18/10万）高于城市地区（中标率18.99/10万，世标率18.56/10万）。结论 福建省肝癌流行呈现地区和性别差异，应从一级预防和二级预防方面开展针对性防控工作。

关键词: 肿瘤登记, 肝癌, 发病率, 死亡率, 福建

Abstract: Objective To analyze the incidence and mortality data of liver cancer in Fujian registration areas in 2017, and to provide scientific basis for the formulation and evaluation of liver cancer prevention and treatment strategies. Methods According to the data review and evaluation method developed by National Central Cancer Registry, the 2017 data reported by 12 cancer registries in Fujian Province were evaluated, among which the data from 10 registries that met the requirements were merged and analyzed. Stratified by areas (urban/rural), gender and age groups, the crude incidence and mortality, standardized rate and cumulative rate (0-74 years) were calculated. The age-standardized rate by Chinese standard population (ASR China)was calculated according to the Chinese standard population in 2000 and the age-standardized rate by world standard population (ASR world) was calculated according to the Segi's population. Results The 10 cancer registries in Fujian Province in 2017 covered a total of 6, 588, 959 registered population, of which urban and rural areas accounted for 43.89% and 56.11%, respectively. In 2017, the incidence of liver cancer in Fujian cancer registration areas was 31.14/105 (male: 48.02/105, female: 13.70/105), with ASR China of 22.51/105 and ASR world of 21.70/105.  The incidence rate in rural areas (ASR China: 23.87/105, ASR world: 22.90/105) was higher than that in urban areas (ASR China: 20.81/105, ASR world: 20.16/105). In 2017, the mortality rate of liver cancer in Fujian cancer registration areas  was 28.09/105 (male: 43.78/105, female: 11.88/105), with ASR China of 20.04/105 and ASR world of 19.45/105. The mortality rate in rural areas (ASR China: 20.91/105, ASR world: 20.18/105) was higher than that in urban areas (ASR China: 18.99/105, ASR world: 18.56/105). Conclusions The prevalence of liver cancer in Fujian Province shows differences in region and gender, and the targeted prevention and control should be carried out from the aspects of primary and secondary preventions.【

Key words: Cancer registration , Liver cancer, Incidence, Mortality, Fujian

中图分类号: 

  • R735.7